-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/new-tf-members-2023-bulletin.pdf
January 01, 2023 - Rao has contributed significantly to the understanding of
cardiovascular disease prevention, hypertension
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/dCH2CMqVyAzf4eyj-ch6H3
August 09, 2016 - Untreated FH is associated with premature cardiovascular disease
in adulthood. … Efficacy and safety of
pitavastatin in children and adolescents at high
future cardiovascular risk. … NHLBI Integrated
Guidelines on Cardiovascular Disease Risk
Reduction: can we clarify the controversy … Lipid
Modification: Cardiovascular Risk Assessment and
the Modification of Blood Lipids for the Primary … and
Secondary Prevention of Cardiovascular Disease.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/3Kwu7j_WfCFQSnSzqrDWwt
June 20, 2019 - A trend
toward increased cardiovascular events (such as transient ische-
mic attack and cerebrovascular … disease are less likely to have a cardiovascular event
with aromatase inhibitor treatment. … Raloxifene and
cardiovascular events in osteoporotic
postmenopausal women: four-year results from
the … Year-by-year analysis of cardiovascular events in the
Multiple Outcomes of Raloxifene Evaluation
(MORE … Effects of raloxifene on
cardiovascular events and breast cancer in
postmenopausal women.
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/reports-congress/seventh-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services
November 01, 2018 - Vision Screening in Children Younger Than Age 3 Years
Statin Use for the Primary Prevention of Cardiovascular
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
September 03, 2019 - The raloxifene trials enrolled older women with osteoporosis 45 , 88-102 or increased cardiovascular … Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. … Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the … Cardiovascular effects of tamoxifen in women with and without heart disease: Breast Cancer Prevention … c Intended treatment duration is 5 years or until a breast, neoplastic, cardiovascular, or toxicity
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan141/obesity-in-children-and-adolescents-screening-june-2017
February 12, 2015 - Abbreviations: BMI = body mass index; CV = cardiovascular; KQ = key question; QOL = quality of life. … obesity-related medical problems (e.g., diabetes, metabolic syndrome, hypertension, lipid abnormalities, or other cardiovascular-related
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/kHT3WGUaG2wTz2pF_ke7bn
KQ5:
Total adverse events
Total serious adverse events
Specific serious adverse events:
major cardiovascular … events
(i.e., myocardial infarction,
stroke, cardiovascular death),
atrial fibrillation, osteonecrosis
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/conflict-interest-disclosures
March 01, 2025 - (Tonette) Krousel-Wood: Topic: Healthy Diet, Physical Activity, and/or Weight Loss to Prevent Cardiovascular
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/c-7ARQE9RuXKjjpeLABkaH
March 01, 2007 - There is fair evidence that aspirin used in doses higher
than those recommended for prevention of cardiovascular … Cyclooxygenase-2 inhibitors appear to be as-
sociated with an increased risk for cardiovascular events … primary pre-
vention RCTs examining aspirin chemoprevention in pa-
tients without previously known cardiovascular … Aspirin for the primary
prevention of cardiovascular events: a summary of the evidence for the U.S.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/6XMRch-R3m4UMVoBMcv43f
December 01, 2007 - addition, clinicians should discuss
aspirin chemoprevention for patients who have an in-
creased risk for cardiovascular … in unselected populations but advised that screening of
adults age 65 years or older with 3 or more cardiovascular … factors, such as a history of hypertension, di-
abetes mellitus, smoking, hypercholesterolemia, or known
cardiovascular … Council: cosponsored by the
Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group;
Cardiovascular
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/xt2Uhv4qyLUZ8o2HB_a4YQ
July 01, 2013 - and anti-
retroviral therapy (ART) use on risky behaviors and HIV transmis-
sion risk; and long-term cardiovascular … Better evidence is needed
about the long-term harms of ART, including risks for
cardiovascular and kidney … Longer-term use of
ART regimens may increase the risk for cardiovascular and
bone disease, as well as … A small increase in cardiovascular risk has been associ-
ated with specific protease inhibitors and nucleoside … Subsequent analyses from the DAD study (36–38) and
other cohort studies (39, 40) also report cardiovascular
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/mggnaKHr496c8QCgHe9-tm
May 01, 2021 - One large randomized clinical trial (SUMMIT; n = 16 590) in
persons with or at risk for cardiovascular … No studies showed that treatment reduced cardiovascular morbid-
ity or mortality or all-cause mortality … One study of cardiovascular risk associated with treatment with
LABAs or LAMAs found an increased risk … 183 858;
adjusted odds ratio, 1.50 [95% CI, 1.35-1.67] and 1.52 [95% CI, 1.28-
1.80], respectively); cardiovascular
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/osteoporosis-screening
November 18, 2021 - Specific serious adverse events: Major cardiovascular events (i.e., myocardial infarction, stroke, cardiovascular
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/uM5P-6XpsqVfEC2axGnZaD
November 16, 2020 - • Harms of NRT include irritation at nicotine exposure site, chest
pain, arrhythmia, and minor cardiovascular … • Use of varenicline was not associated with cardiovascular or
neuropsychiatric adverse events but … Statistically significantly more cardiovascular adverse
events (in particular, heart palpitations and … Cardiovascular events associated with
smoking cessation pharmacotherapies: a network
meta-analysis. … Cardiovascular safety of varenicline, bupropion, and
nicotine patch in smokers: a randomized clinical
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-children-and-adolescents-screening-2005
July 12, 2005 - Risk of cardiovascular complication. In: Burniat W, Cole T, Lissau I, Poskitt EME, editors. … Can cardiovascular risk be predicted by newborn, childhood, and adolescent body size? … The emergence of clinically abnormal levels of cardiovascular disease risk factor variables among young … Transitions of cardiovascular risk from adolescence to young adulthood—the Bogalusa Heart Study: II. … Effects of exercise intensity on cardiovascular fitness, total body composition, and visceral adiposity
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/child-lipid-screening-draft-rec-bulletin.pdf
February 21, 2023 - “Good nutrition and physical activity habits begin in childhood and
can improve cardiovascular health
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening-1996
January 01, 1996 - diagnosed by B-mode ultrasound, lovastatin induced regression of atherosclerosis and reduced total cardiovascular … auscultation for carotid bruits in people age 40 and older with risk factors for cerebrovascular or cardiovascular … disease, those with neurologic symptoms (e.g., TIA) or those with a history of cardiovascular disease … Effect of lovastatin on early carotid atherosclerosis and cardiovascular events.
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfannrpt2011.pdf
January 01, 2012 - (Falls Prevention in Older Adults, Counseling to Promote a Healthy Diet and Physical Activity
for Cardiovascular … B
Healthy Diet: Counseling for Adults With Hyperlipidemia and Other Risk Factors for Cardiovascular … D
Vitamin Supplementation to Prevent Cancer and Cardiovascular Disease: Beta Carotene
The USPSTF recommends … I
Aspirin to Prevent Cardiovascular Disease: Adults Ages 80 Years or Older
The USPSTF concludes that … I
Vitamin Supplementation to Prevent Cancer and Cardiovascular Disease: Vitamins A, C, E, and Multivitamins
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/task-force-resources
June 22, 2025 - patients about whether starting aspirin may be right for people 40 and older who might be at high risk for cardiovascular
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan18/drug-use-illicit-primary-care-interventions-for-children-and-adolescents-march-2014
May 15, 2013 - hepatitis B or C transmission, unintended pregnancies/pregnancy complications, respiratory infections, cardiovascular … Serious treatment-related harms at any time point after the intervention began (e.g., death, seizure, cardiovascular